Merit Medical Systems annual total liabilities
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Merit Medical Systems Total Liabilities Growth & History (MMSI)
Merit Medical Systems's total liabilities was $1.10B for fiscal 2025.
View full Merit Medical Systems company overviewMerit Medical Systems annual total liabilities history
| Fiscal year | Period ended | Total liabilities | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $1.10B | $62.4M | +6.00% |
| 2024 | 2024-12-31 | $1.04B | −$84.0M | −7.48% |
| 2023 | 2023-12-31 | $1.12B | $603.7M | +116.19% |
| 2022 | 2022-12-31 | $519.6M | −$88.9M | −14.61% |
| 2021 | 2021-12-31 | $608.5M | −$97.3M | −13.79% |
| 2020 | 2020-12-31 | $705.8M | −$101.6M | −12.58% |
| 2019 | 2019-12-31 | $807.4M | $120.1M | +17.48% |
| 2018 | 2018-12-31 | $687.2M | $251.8M | +57.81% |
| 2017 | 2017-12-31 | $435.5M | −$9.1M | −2.06% |
| 2016 | 2016-12-31 | $444.6M | $132.0M | +42.22% |
| 2015 | 2015-12-31 | $312.6M | $719,000 | +0.23% |
| 2014 | 2014-12-31 | $311.9M | −$10.7M | −3.31% |
| 2013 | 2013-12-31 | $322.6M | −$1.2M | −0.36% |
| 2012 | 2012-12-31 | $323.7M | $233.8M | +259.99% |
| 2011 | 2011-12-31 | $89.9M | −$43.9M | −32.82% |
| 2010 | 2010-12-31 | $133.9M | $81.2M | +153.99% |
| 2009 | 2009-12-31 | $52.7M | — | — |
Merit Medical Systems quarterly total liabilities
Q4.10
Q2.11
Q3.11
Q4.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total liabilities | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $1.18B | $85.8M | +7.82% |
| Q1 2026 | 2026-03-31 | $1.09B | $53.0M | +5.10% |
| Q4 2025 | 2025-12-31 | $1.10B | $62.4M | +6.00% |
| Q3 2025 | 2025-09-30 | $1.10B | $46.9M | +4.45% |
| Q2 2025 | 2025-06-30 | $1.10B | $8.6M | +0.79% |
| Q1 2025 | 2025-03-31 | $1.04B | −$46.6M | −4.29% |
| Q4 2024 | 2024-12-31 | $1.04B | −$84.0M | −7.48% |
| Q3 2024 | 2024-09-30 | $1.05B | $476.1M | +82.27% |
| Q2 2024 | 2024-06-30 | $1.09B | $455.5M | +71.86% |
| Q1 2024 | 2024-03-31 | $1.09B | $573.7M | +111.95% |
| Q4 2023 | 2023-12-31 | $1.12B | $603.7M | +116.19% |
| Q3 2023 | 2023-09-30 | $578.6M | $34.7M | +6.38% |
| Q2 2023 | 2023-06-30 | $633.9M | $75.7M | +13.55% |
| Q1 2023 | 2023-03-31 | $512.5M | −$60.8M | −10.60% |
| Q4 2022 | 2022-12-31 | $519.6M | −$88.9M | −14.61% |
| Q3 2022 | 2022-09-30 | $543.9M | −$85.9M | −13.64% |
| Q2 2022 | 2022-06-30 | $558.2M | −$91.7M | −14.12% |
| Q1 2022 | 2022-03-31 | $573.2M | −$101.8M | −15.08% |
| Q4 2021 | 2021-12-31 | $608.5M | −$97.3M | −13.79% |
| Q3 2021 | 2021-09-30 | $629.8M | −$106.9M | −14.51% |
| Q2 2021 | 2021-06-30 | $650.0M | −$137.1M | −17.42% |
| Q1 2021 | 2021-03-31 | $675.0M | −$134.4M | −16.61% |
| Q4 2020 | 2020-12-31 | $705.8M | −$101.6M | −12.58% |
| Q3 2020 | 2020-09-30 | $736.7M | −$75.8M | −9.33% |
| Q2 2020 | 2020-06-30 | $787.0M | $1.4M | +0.18% |
| Q1 2020 | 2020-03-31 | $809.5M | $59.8M | +7.98% |
| Q4 2019 | 2019-12-31 | $807.4M | $120.1M | +17.48% |
| Q3 2019 | 2019-09-30 | $812.5M | $425.8M | +110.12% |
| Q2 2019 | 2019-06-30 | $785.6M | $193.7M | +32.72% |
| Q1 2019 | 2019-03-31 | $749.7M | $199.0M | +36.13% |
| Q4 2018 | 2018-12-31 | $687.2M | $251.8M | +57.81% |
| Q3 2018 | 2018-09-30 | $386.7M | −$33.7M | −8.01% |
| Q2 2018 | 2018-06-30 | $591.9M | $206.6M | +53.60% |
| Q1 2018 | 2018-03-31 | $550.7M | $187.9M | +51.77% |
| Q4 2017 | 2017-12-31 | $435.5M | −$9.1M | −2.06% |
| Q3 2017 | 2017-09-30 | $420.3M | −$22.3M | −5.04% |
| Q2 2017 | 2017-06-30 | $385.4M | $50.4M | +15.04% |
| Q1 2017 | 2017-03-31 | $362.8M | $31.7M | +9.59% |
| Q4 2016 | 2016-12-31 | $444.6M | $132.0M | +42.22% |
| Q3 2016 | 2016-09-30 | $442.7M | $133.2M | +43.03% |
| Q2 2016 | 2016-06-30 | $335.0M | $32.7M | +10.80% |
| Q1 2016 | 2016-03-31 | $331.1M | $33.8M | +11.36% |
| Q4 2015 | 2015-12-31 | $312.6M | $719,000 | +0.23% |
| Q3 2015 | 2015-09-30 | $309.5M | −$12.8M | −3.96% |
| Q2 2015 | 2015-06-30 | $302.3M | −$25.9M | −7.89% |
| Q1 2015 | 2015-03-31 | $297.3M | −$34.9M | −10.49% |
| Q4 2014 | 2014-12-31 | $311.9M | −$10.7M | −3.31% |
| Q3 2014 | 2014-09-30 | $322.3M | −$299,000 | −0.09% |
| Q2 2014 | 2014-06-30 | $328.2M | −$10.6M | −3.13% |
| Q1 2014 | 2014-03-31 | $332.2M | $3.4M | +1.03% |
| Q4 2013 | 2013-12-31 | $322.6M | −$1.2M | −0.36% |
| Q3 2013 | 2013-09-30 | $322.6M | $184.4M | +133.48% |
| Q2 2013 | 2013-06-30 | $338.8M | $209.2M | +161.44% |
| Q1 2013 | 2013-03-31 | $328.8M | $203.2M | +161.76% |
| Q4 2012 | 2012-12-31 | $323.7M | $233.8M | +259.99% |
| Q3 2012 | 2012-09-30 | $138.2M | $70.0M | +102.82% |
| Q2 2012 | 2012-06-30 | $129.6M | $17.7M | +15.82% |
| Q1 2012 | 2012-03-31 | $125.6M | — | — |
| Q4 2011 | 2011-12-31 | $89.9M | −$43.9M | −32.82% |
| Q3 2011 | 2011-09-30 | $68.1M | — | — |
| Q2 2011 | 2011-06-30 | $111.9M | — | — |
| Q4 2010 | 2010-12-31 | $133.9M | — | — |
Merit Medical Systems total liabilities trends
Over the last five fiscal years, Merit Medical Systems's total liabilities increased from $705.8M to $1.10B, a change of $395.8M. The latest reported quarter, Q2 2026, shows $1.18B.
About the metric
What total liabilities mean
Total liabilities are all obligations reported on a company’s balance sheet, including debt, accounts payable, accrued expenses, deferred revenue, lease liabilities, and other current and long-term obligations.
Calculation and source
SEC-reported and calculated total liabilities
TickerStat uses total liabilities reported in company SEC filings when available. Otherwise, it calculates total liabilities as aligned total assets minus total equity for the same balance-sheet date. Total liabilities should not be confused with interest-bearing debt. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Merit Medical Systems source filings ↗Community posts
Merit raises earnings guidance and discloses its completed Solo Pace acquisition
Merit Medical ($MMSI) raised its 2026 adjusted EPS forecast to $4.33–$4.37 from $4.25–$4.35 after third-quarter 2026 revenue increased 8.4% to $416.2 million. Organic growth at constant currency was 9%. Adjusted quarterly EPS rose 22% to $1 ...
